Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Los Alamitos. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in Los Alamitos at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
This study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared to placebo. MET097 or placebo will be administered to individuals via subcutaneous injection once weekly for 28 weeks. If an individual is randomly assigned to MET097 they will receive one of four different dose regimens.
Sponsor: Metsera
Check if you qualify for this type 2 diabetes clinical trial in Los Alamitos, CA
If you're searching for type 2 diabetes treatment options in Los Alamitos, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Alamitos research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.